Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 20646772)

  • 1. Epigenetic regulation of cancer stem cells in liver cancer: current concepts and clinical implications.
    Marquardt JU; Factor VM; Thorgeirsson SS
    J Hepatol; 2010 Sep; 53(3):568-77. PubMed ID: 20646772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic imbalance between cancer cell subpopulations induced by transforming growth factor beta (TGF-β) is associated with a DNA methylome switch.
    Martin M; Ancey PB; Cros MP; Durand G; Le Calvez-Kelm F; Hernandez-Vargas H; Herceg Z
    BMC Genomics; 2014 Jun; 15(1):435. PubMed ID: 24898317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer stem cells in lung cancer: Evidence and controversies.
    Alamgeer M; Peacock CD; Matsui W; Ganju V; Watkins DN
    Respirology; 2013 Jul; 18(5):757-64. PubMed ID: 23586700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metadherin-driven promotion of cancer stem cell phenotypes and its effect on immunity in hepatocellular carcinoma.
    Todorović N; Amedei A
    World J Gastroenterol; 2024 May; 30(20):2624-2628. PubMed ID: 38855151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer stem cells: implications for the progression and treatment of metastatic disease.
    Croker AK; Allan AL
    J Cell Mol Med; 2008 Apr; 12(2):374-90. PubMed ID: 18182063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lessons from common markers of tumor-initiating cells in solid cancers.
    Gires O
    Cell Mol Life Sci; 2011 Dec; 68(24):4009-22. PubMed ID: 21786143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential Role of Nrf2, HER2, and ALDH in Cancer Stem Cells: A Narrative Review.
    Fakhrioliaei A; Tanhaei S; Pakmehr S; Noori Shakir M; Qasim MT; Hariri M; Nouhi Kararoudi A; Valilo M
    J Membr Biol; 2024 Apr; 257(1-2):3-16. PubMed ID: 38356054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging roles of Myc in stem cell biology and novel tumor therapies.
    Yoshida GJ
    J Exp Clin Cancer Res; 2018 Jul; 37(1):173. PubMed ID: 30053872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update.
    Takebe N; Miele L; Harris PJ; Jeong W; Bando H; Kahn M; Yang SX; Ivy SP
    Nat Rev Clin Oncol; 2015 Aug; 12(8):445-64. PubMed ID: 25850553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling pathogenesis of primary liver cancer in lineage-specific mouse cell types.
    Holczbauer Á; Factor VM; Andersen JB; Marquardt JU; Kleiner DE; Raggi C; Kitade M; Seo D; Akita H; Durkin ME; Thorgeirsson SS
    Gastroenterology; 2013 Jul; 145(1):221-231. PubMed ID: 23523670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Informed by Cancer Stem Cells of Solid Tumors: Advances in Treatments Targeting Tumor-Promoting Factors and Pathways.
    MacLean MR; Walker OL; Arun RP; Fernando W; Marcato P
    Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview of Cancer Stem Cells and Stemness for Community Oncologists.
    Lathia JD; Liu H
    Target Oncol; 2017 Aug; 12(4):387-399. PubMed ID: 28664387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lung Cancer Stem Cells and Their Clinical Implications.
    Rowbotham SP; Goruganthu MUL; Arasada RR; Wang WZ; Carbone DP; Kim CF
    Cold Spring Harb Perspect Med; 2022 May; 12(4):. PubMed ID: 34580078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA100 inhibits self-renewal of breast cancer stem-like cells and breast tumor development.
    Deng L; Shang L; Bai S; Chen J; He X; Martin-Trevino R; Chen S; Li XY; Meng X; Yu B; Wang X; Liu Y; McDermott SP; Ariazi AE; Ginestier C; Ibarra I; Ke J; Luther T; Clouthier SG; Xu L; Shan G; Song E; Yao H; Hannon GJ; Weiss SJ; Wicha MS; Liu S
    Cancer Res; 2014 Nov; 74(22):6648-60. PubMed ID: 25217527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-fetoprotein, stem cells and cancer: how study of the production of alpha-fetoprotein during chemical hepatocarcinogenesis led to reaffirmation of the stem cell theory of cancer.
    Sell S
    Tumour Biol; 2008; 29(3):161-80. PubMed ID: 18612221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The increasing complexity of the cancer stem cell paradigm.
    Rosen JM; Jordan CT
    Science; 2009 Jun; 324(5935):1670-3. PubMed ID: 19556499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastatic stem cells: sources, niches, and vital pathways.
    Oskarsson T; Batlle E; Massagué J
    Cell Stem Cell; 2014 Mar; 14(3):306-21. PubMed ID: 24607405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The significance of intertumor and intratumor heterogeneity in liver cancer.
    Liu J; Dang H; Wang XW
    Exp Mol Med; 2018 Jan; 50(1):e416. PubMed ID: 29303512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer stem cells.
    Yasui W; Nishikawa S; Tahara E
    Cancer Sci; 2007 May; 98(5):753-6. PubMed ID: 17374123
    [No Abstract]   [Full Text] [Related]  

  • 20. Clonal tracking in cancer and metastasis.
    Aalam SMM; Nguyen LV; Ritting ML; Kannan N
    Cancer Metastasis Rev; 2024 Jun; 43(2):639-656. PubMed ID: 37910295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.